{"id":"W2526090031","doi":"10.1016/j.jcjd.2016.08.114","title":"Efficacy and Safety of Once-Weekly Semaglutide vs. Exenatide ER after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 3)","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Semaglutide; Medicine; Exenatide; Sulfonylurea; Type 2 diabetes; Glycated hemoglobin; Metformin; Dulaglutide; Clinical endpoint; Internal medicine; Glucagon-like peptide-1; Diabetes mellitus; Pharmacology; Endocrinology; Randomized controlled trial; Liraglutide","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001098633,0.0006933243,0.002385932,0.0003316986,0.0003295314,0.000853872,0.0004983321,0.0009390885,0.00291999],"category_scores_gemma":[0.001155147,0.0003758868,0.002103677,0.0003246512,0.0004314875,0.001091063,0.0003495712,0.001768598,0.0005969722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004553786,"about_ca_system_score_gemma":0.0005692684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001182316,"about_ca_topic_score_gemma":0.001779178,"domain_scores_codex":[0.9996934,0.0000911954,0.00003076303,0.00007025019,0.00003445673,0.00007994136],"domain_scores_gemma":[0.9994331,0.0001199583,0.0001379696,0.00007966123,0.00003700862,0.0001922013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9468418,0.005724605,0.006932896,0.0001609508,0.0006483544,0.00006445241,0.00007692073,0.0003812631,0.004921575,0.0000359125,0.0002042118,0.034007],"study_design_scores_gemma":[0.3341294,0.4814938,0.1717826,0.0001615847,0.003919532,0.000247195,0.0003371097,0.00217501,0.003973657,0.0002935504,0.001357002,0.0001295794],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998023,0.000984551,0.00005824536,0.00006904083,0.00003919915,0.00005662184,0.0002365892,0.00003029844,0.00050257],"genre_scores_gemma":[0.9973199,0.0006235237,0.0001663821,0.0001342867,0.00008290858,0.0001000757,0.0004951326,0.0000118844,0.001065952],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00291999,"threshold_uncertainty_score":0.009768367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005924468035575592,"score_gpt":0.2047414380720541,"score_spread":0.1988169700364786,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}